Tag: Co-Commercialisation
Sidley guides USD2.1bn Telix radiopharmaceutical collaboration
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
Japanese corporates have been actively turning to the overseas M&A market for expanding their business and enhancing capital efficiency
An unprecedented transfer of private wealth is colliding with tighter regulation and rising complexity
South Korea’s maritime hub status grows with advanced ports, shipbuilding strength, trade volumes and dispute resolution.